Hydrocortisone butyrate 1 MG/ML Topical Lotion — RxCUI 1370763
RxNorm drug concept · Semantic clinical drug
RxCUI 1370763
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1370763
Official nameHydrocortisone butyrate 1 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone butyrate 0.1 % Topical Lotion
FDA products mapped4
Package NDCs mapped7
Reported Medicaid activity (SDUD)2,800 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
- What exactly is this enema treating — is it the same as regular colitis medicine?
- Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
- How long do I need to use it before it starts working?
🕸️ Concept Web — How Hydrocortisone butyrate 1 MG/ML Topical Lotion Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydrocortisone butyrate 1 MG/ML Topical Lotion
RxCUI 1370763 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hydrocortisone
5492IN -
Hydrocortisone butyrate
103468PIN
-
Hydrocortisone
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Evesse
2742556BN -
Locoid
52147BN
-
Evesse
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydrocortisone Topical Lotion
377713SCDF -
Hydrocortisone butyrate Topical Lotion
2645482SCDFP -
Hydrocortisone Topical Product
1164013SCDG -
Hydrocortisone butyrate Topical Product
2662286SCDGP -
Hydrocortisone Topical Lotion [Evesse]
2742559SBDF -
Hydrocortisone Topical Lotion [Locoid]
385399SBDF -
Hydrocortisone butyrate Topical Lotion [Evesse]
2742560SBDFP -
Hydrocortisone butyrate Topical Lotion [Locoid]
2655986SBDFP - +4 more in this family
-
Hydrocortisone Topical Lotion
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydrocortisone butyrate 1 MG/ML
1370762SCDC -
Hydrocortisone butyrate 1 MG/ML Topical Lotion [Evesse]
2742561SBD -
Hydrocortisone butyrate 1 MG/ML Topical Lotion [Locoid]
1370765SBD -
Hydrocortisone butyrate 1 MG/ML [Evesse]
2742557SBDC -
Hydrocortisone butyrate 1 MG/ML [Locoid]
1370764SBDC
-
Hydrocortisone butyrate 1 MG/ML
Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydrocortisone butyrate 1 MG/ML
SCDC · 1370762 -
Hydrocortisone Topical Lotion
SCDF · 377713 -
Hydrocortisone butyrate Topical Lotion
SCDFP · 2645482 -
Hydrocortisone Topical Product
SCDG · 1164013 -
Hydrocortisone butyrate Topical Product
SCDGP · 2662286
Brand-Name Concepts
-
Hydrocortisone butyrate 1 MG/ML Topical Lotion [Evesse]
SBD · 2742561 -
Hydrocortisone butyrate 1 MG/ML Topical Lotion [Locoid]
SBD · 1370765 -
Hydrocortisone butyrate 1 MG/ML [Evesse]
SBDC · 2742557 -
Hydrocortisone butyrate 1 MG/ML [Locoid]
SBDC · 1370764 -
Hydrocortisone Topical Lotion [Evesse]
SBDF · 2742559 -
Hydrocortisone Topical Lotion [Locoid]
SBDF · 385399 -
Hydrocortisone butyrate Topical Lotion [Evesse]
SBDFP · 2742560 -
Hydrocortisone butyrate Topical Lotion [Locoid]
SBDFP · 2655986 -
Evesse Topical Product
SBDG · 2742558 -
Locoid Topical Product
SBDG · 1179154
📦 FDA Products & Package NDCs
4 products · 7 package NDCs
7 package NDCs map to RxCUI 1370763 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68180-0951-01 | 1 BOTTLE in 1 CARTON (68180-951-01) / 59 mL in 1 BOTTLE | Hydrocortisone Butyrate | Lupin Pharmaceuticals, Inc. | 2018-08-17 |
| 68180-0951-02 | 1 BOTTLE in 1 CARTON (68180-951-02) / 118 mL in 1 BOTTLE | Hydrocortisone Butyrate | Lupin Pharmaceuticals, Inc. | 2018-08-17 |
| 72162-2630-02 | 1 BOTTLE in 1 CARTON (72162-2630-2) / 59 mL in 1 BOTTLE | Hydrocortisone Butyrate | Bryant Ranch Prepack | 2026-04-23 |
| 72162-2630-04 | 1 BOTTLE in 1 CARTON (72162-2630-4) / 118 mL in 1 BOTTLE | Hydrocortisone Butyrate | Bryant Ranch Prepack | 2026-04-23 |
| 83148-0012-02 | 1 BOTTLE in 1 CARTON (83148-012-02) / 59 mL in 1 BOTTLE | Hydrocortisone Butyrate | The J. Molner Company LLC | 2023-11-06 |
| 83148-0012-04 | 1 BOTTLE in 1 CARTON (83148-012-04) / 118 mL in 1 BOTTLE | Hydrocortisone Butyrate | The J. Molner Company LLC | 2023-11-06 |
| 87143-0420-04 | 118 mL in 1 BOTTLE (87143-420-04) | Evesse | Perfero Pharma, Inc. | 2026-05-04 |
Observed labelers:
Bryant Ranch Prepack (2) ·
Lupin Pharmaceuticals, Inc. (2) ·
The J. Molner Company LLC (2) ·
Perfero Pharma, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.7000
Range $0.7000–$0.7000
· middle 50% $0.7000–$0.7000
· 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.